Stocks


 Research reveals that Nyrada's leading medication can avert secondary brain injury.

Research reveals that Nyrada's leading medication can avert secondary brain injury.

April 07, 2025 10:30 AM AEST| By Team Kalkine Media

Highlights:,Nyrada Inc has released new findings from a study showing its drug candidate NYR-BI03 demonstrates neuroprotective effects following traumatic brain injury.,The research, conducted with the University of Sydney, Walter Reed Army Institute...

 Exploring Penny Stocks Amid Market Volatility

Exploring Penny Stocks Amid Market Volatility

April 07, 2025 08:30 AM AEST| By Team Kalkine Media

Highlights,Australian market anticipates potential downturn led by ASX 200 futures.,Penny stocks in focus as investors seek financially resilient options.,Insight into the financial health of selected Australian penny stocks.,As Australian shares fac...

 Positively Undervalued ASX Stocks in April 2025

Positively Undervalued ASX Stocks in April 2025

April 07, 2025 08:30 AM AEST| By Team Kalkine Media

Highlights,Global tariff tensions affect Australian stock projections.,Undervalued stocks offer intriguing possibilities for investors.,Careful evaluation of company fundamentals is essential.,Amid the backdrop of global tariff tensions and their imp...

 Is Investing in Alara Resources (ASX:AUQ) Risky?

Is Investing in Alara Resources (ASX:AUQ) Risky?

April 06, 2025 06:30 PM AEST| By Team Kalkine Media

Highlights,Debt levels raise concerns for Alara Resources' stability.,Current liabilities significantly outweigh cash and receivables.,Investors wary due to recent financial performance.,Warren Buffett once remarked that volatility does not equate to...

 Examining the Intrinsic Value of Xero Limited (ASX:XRO)

Examining the Intrinsic Value of Xero Limited (ASX:XRO)

April 06, 2025 06:30 PM AEST| By Team Kalkine Media

Highlights,Xero's current share price aligns closely with its estimated fair value of AU$132,Discounted Cash Flow (DCF) model utilized to project valuation,The analyst price target of NZ$187 suggests a potential upward trend,Exploring the investment...

 These Four Indicators Show That Eagers Automotive (ASX:APE) is Heavily Relying on Debt

These Four Indicators Show That Eagers Automotive (ASX:APE) is Heavily Relying on Debt

April 06, 2025 12:31 PM AEST| By Team Kalkine Media

Highlights,Eagers Automotive's debt levels are noteworthy compared to its EBITDA.,Interest coverage ratio indicates potential challenges in managing debt.,Free cash flow conversion from EBIT presents a mixed financial outlook.,Renowned investor Warre...

 Cochlear Limited's (ASX:COH) Shares May Face Unwelcome Surprises

Cochlear Limited's (ASX:COH) Shares May Face Unwelcome Surprises

April 06, 2025 12:31 PM AEST| By Team Kalkine Media

Highlights,Cochlear Limited (ASX:COH) holds a P/E ratio significantly higher than the Australian market average.,The company has demonstrated robust historical earnings growth.,Investors appear optimistic about Cochlear's future, potentially pricing...

 Oneview Healthcare (ASX:ONE) Insider Activity Overview

Oneview Healthcare (ASX:ONE) Insider Activity Overview

April 06, 2025 12:31 PM AEST| By Team Kalkine Media

Highlights,Insiders purchased more shares than they divested over the past year.,Insider ownership stands at a significant 42% of the company.,Recent insider transaction trends show confidence in future prospects.,Despite the recent 16% dip in share...

 Johns Lyng Group (ASX:JLG): An Overview of Recent Developments

Johns Lyng Group (ASX:JLG): An Overview of Recent Developments

April 06, 2025 12:31 PM AEST| By Team Kalkine Media

Highlights,Significant decline in Johns Lyng Group (JLG) stock over the past year,Current P/E ratio aligns with market average,Analysts forecast moderate earning growth,Shareholders of Johns Lyng Group Limited (ASX:JLG) have faced challenging times w...

 Domino's Pizza Enterprises (ASX:DMP) Assumes Risk Through Its Debt Utilization

Domino's Pizza Enterprises (ASX:DMP) Assumes Risk Through Its Debt Utilization

April 06, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights,Domino's Pizza Enterprises (DMP) carries significant debt but manages it effectively.,Current liabilities exceed the available cash and short-term receivables of the company.,Earnings stability and free cash flow provide a cushion for the...

 Examining the Fair Value of Codan Limited (ASX:CDA)

Examining the Fair Value of Codan Limited (ASX:CDA)

April 06, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights,Codan's estimated fair value is AU$18.20 per share.,Current trading price close to fair value estimate at AU$14.64.,Analysis aligns with Codan's analyst price target.,For investors exploring Codan Limited (ASX:CDA), understanding its intri...

 NuEnergy Gas (ASX:NGY) Is Utilizing Debt Conservatively

NuEnergy Gas (ASX:NGY) Is Utilizing Debt Conservatively

April 06, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights,NuEnergy Gas Limited has a manageable debt level with a net debt of AU$356.0k.,The company's liabilities exceed its cash and near-term receivables by AU$11.9m.,Despite its financial challenges, NuEnergy Gas's market cap suggests potential...

 Lifestyle Communities (ASX:LIC): What's Driving Recent Share Price Movements?

Lifestyle Communities (ASX:LIC): What's Driving Recent Share Price Movements?

April 06, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights,LIC noted for significant recent price fluctuation.,Current valuation appears higher than industry peers.,Strong future growth projections for LIC.,Lifestyle Communities Limited (ASX:LIC) might not be the largest cap stock on the market, b...

 Tryptamine Therapeutics: Insider Transactions and Ownership Insights

Tryptamine Therapeutics: Insider Transactions and Ownership Insights

April 05, 2025 05:31 PM AEDT| By Team Kalkine Media

Highlights,Founder William Garner makes significant stock purchase.,Insider ownership stands at 35% of the company.,Recent purchases suggest perceived long-term value.,In recent developments, William Garner, the Founder and Managing Director of Trypt...

 Iress Limited: A Closer Look at Recent Performance

Iress Limited: A Closer Look at Recent Performance

April 05, 2025 05:31 PM AEDT| By Team Kalkine Media

Highlights,Shareholders faced a steep 34% decline over three years.,Recent insider buying noted despite challenging returns.,Total shareholder return offers a broader perspective.,Investors strive for portfolios that outpace the market average, yet n...

 Investors Struggle to Find Optimism in Metcash Limited's (ASX:MTS) Outlook

Investors Struggle to Find Optimism in Metcash Limited's (ASX:MTS) Outlook

April 05, 2025 05:31 PM AEDT| By Team Kalkine Media

Highlights,Metcash Limited's P/E ratio is lower than the market average.,Company's recent earnings growth has been disappointing.,Analysts predict slower future growth compared to the market.,In a market where many Australian stocks exhibit price-to-...

 The growth rate of Nick Scali's (ASX:NCK) earnings falls short of the 36% compound annual growth rate (CAGR) experienced by shareholders.

The growth rate of Nick Scali's (ASX:NCK) earnings falls short of the 36% compound annual growth rate (CAGR) experienced by shareholders.

April 05, 2025 05:30 PM AEDT| By Team Kalkine Media

Higlights,Nick Scali Limited's stock price surged 255% in five years.,The stock recently dipped 6.8%, against a market decline of 1.5%.,Nick Scali's 5-year TSR, including dividends, reached an impressive 373%.,The potential loss on any stock investme...

 ImExHS Shows Upward Trend in Financial Performance

ImExHS Shows Upward Trend in Financial Performance

April 05, 2025 05:30 PM AEDT| By Team Kalkine Media

Highlights,ImExHS (IME) sees revenue growth by 33% in FY 2024.,Net loss narrows by 41% from the previous year.,Radiology segment leads with 68% of total revenue.,ImExHS (ASX:IME) has reported its Full Year 2024 financial results, showcasing a signifi...

 Hydration Pharmaceuticals' 2024 Financial Overview

Hydration Pharmaceuticals' 2024 Financial Overview

April 05, 2025 05:30 PM AEDT| By Team Kalkine Media

Highlights,Steady revenues reported at $3.20 million.,Net losses have decreased significantly.,Focus remains on cost management and efficiency.,Hydration Pharmaceuticals, recognized by its ticker,(ASX:HPC),, has recently released its full-year 2024 f...

 Determining the Fair Value of XRF Scientific Limited (ASX:XRF)

Determining the Fair Value of XRF Scientific Limited (ASX:XRF)

April 05, 2025 11:33 AM AEDT| By Team Kalkine Media

Highlights,XRF Scientific's intrinsic value estimated at AU$2.02 per share.,Current trading price suggests it's close to fair value.,Peers are valued significantly higher, trading at a 185% premium.,Understanding a stock's intrinsic value can be cruc...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.